0
0
Tracking the FDA advisory panel on Sarepta's gene therapy - STAT
5/12/23 at 8:34am
Organization
STAT
Authors
Adam Feuerstein Jason Mast
29 words
0
Comments
We're live-blogging today's FDA advisory panel on Sarepta’s gene therapy for Duchenne muscular dystrophy.
2 similar articles
FDA advisers narrowly vote in favor of experimental gene therapy for rare muscle disease - CNN
FDA adcomm backs accelerated approval of Sarepta's Duchenne gene therapy in close vote - Endpoints News
You are the first to view
https://www.statnews.com/2023/05/12/sarepta-gene-therapy-duchenne-muscular-dystrophy-fda-advisory-panel/
Create an account or login to join the discussion